Efficacy and safety of risankizumab in patients with erythrodermic and sub-erythrodermic psoriasis: a case series. Dermatol Reports [Internet]. 2025 Jul. 30 [cited 2025 Aug. 4];. Available from: https://journals.pagepress.org/dr/article/view/10379